The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGRA.L Regulatory News (GRA)

  • There is currently no data for GRA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re. the sale of Works Manchester Limited

1 Jun 2023 07:00

RNS Number : 2561B
Grafenia plc
01 June 2023
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation. With the publication of this announcement, this information is now considered to be in the public domain.

1 June 2023

 

Grafenia plc

("Grafenia" or "the Company" or the "Group")

 

Update regarding the sale of Works Manchester Limited

 

Grafenia plc (AIM: GRA) announces the following update regarding the sale of Works Manchester Limited which was undertaken to enable the Group to focus on its stated aim of becoming a serial acquirer of vertical market software businesses.

 

On the 19 May 2022, the Company announced it had agreed to sell its wholly-owned subsidiary, Works Manchester Limited ("Works Manchester"), formerly Image Everything Limited, and certain business and assets of its wholly-owned subsidiary Grafenia Operations Limited ("Grafenia Operations") (together, the "Disposal") to Rymack Sign Solutions Limited, a privately owned company trading as PFI Group ("PFI").

 

The Disposal to PFI completed on 31 May 2022 and, pursuant to the sale and purchase agreement entered into between PFI and Grafenia, Grafenia was to receive consideration of £3,165,000 payable in the following installments:

 

- £30,000 on completion

- £35,000 one month following completion;

- £35,000 two months following completion;

- Four installments of £766,250 on the first, second, third and fourth anniversaries of completion (the "Deferred Consideration").

 

The first installment of Deferred Consideration was subject to adjustment for any shortfall or excess in actual net assets on completion versus estimated net assets prior to completion. Following the preparation and agreement of completion accounts, the first installment of Deferred Consideration was adjusted to £514,223 (the "Adjusted Installment").

 

PFI has yet to make payment of the Adjusted Installment which was due on 31 May 2023 and the Company is in discussions with PFI to resolve the matter. A further update will be provided in due course.

 

As reported in its Pre-close statement and Trading Update on 3 May 2023, the Company has made significant progress in pursuing its new strategy and is currently considering raising additional funding to enable this to continue.

 

For further information:

 

Grafenia plc

Gavin Cockerill 07968 510 662

 

Allenby Capital Limited (Nominated Adviser and Broker)

 

David Hart / Piers Shimwell (Corporate Finance) 0203 328 5656

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEANSFDLKDEFA
Date   Source Headline
17th Oct 20237:00 amRNSChange of Company name effective
16th Oct 20236:30 pmRNSDirector/PDMR Shareholding
6th Oct 20239:37 amRNSGrant of options
26th Sep 202312:21 pmRNSResult of AGM and Change of Name and Website
21st Sep 20237:00 amRNSHolding(s) in Company
20th Sep 20235:39 pmRNSHolding(s) in Company
15th Sep 20235:47 pmRNSReplacement: Result of GM and Open Offer
15th Sep 202310:22 amRNSResult of General Meeting and Open Offer
8th Sep 20232:03 pmRNSDirector/PDMR Shareholding
29th Aug 20237:00 amRNSFundraise of up to £27.9 million and other matters
26th Jul 20237:00 amRNSFinal Results
1st Jun 20237:00 amRNSUpdate re. the sale of Works Manchester Limited
3rd May 20237:00 amRNSPre-close statement and Trading Update
3rd Apr 20231:13 pmRNSHolding(s) in Company
17th Feb 202312:35 pmRNSAcquisition of Topfloor Systems Limited
20th Jan 20232:49 pmRNSBond Issue
18th Jan 20237:00 amRNSAcquisition of Care Management Systems Limited
28th Dec 20227:00 amRNSHolding(s) in Company
13th Dec 20227:00 amRNSReplacement: Bond Issue
12th Dec 20225:51 pmRNSBond Issue
7th Dec 20225:07 pmRNSAcquisition of Watermark Technologies Limited
24th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSBoard Appointment
7th Oct 202211:37 amRNSHolding(s) in Company
6th Oct 20221:48 pmRNSHolding(s) in Company
27th Sep 202212:56 pmRNSBond Issue
22nd Sep 20224:09 pmRNSAcquisition of Vertical Plus Limited
14th Sep 20222:18 pmRNSResult of AGM
27th Jul 20223:18 pmRNSReplacement: Final Results
27th Jul 20227:00 amRNSFinal Results
19th May 20227:00 amRNSSale of Subsidiary and Board Changes
4th May 20229:01 amRNSDirector/PDMR Shareholding
6th Apr 202212:00 pmRNSPre-close statement and Trading Update
22nd Nov 20217:00 amRNSHalf-year Report
15th Sep 202110:35 amRNSResult of AGM
15th Sep 20217:00 amRNSAGM Trading Statement
28th Jul 20217:00 amRNSFinal Results
16th Apr 20217:00 amRNSPre-close Trading and Strategy Update
3rd Mar 20217:00 amRNSBlock admission review & block cancellation
8th Jan 202112:38 pmRNSStmnt re Share Price Movement
31st Dec 20201:00 pmRNSTotal Voting Rights
14th Dec 20203:45 pmRNSIssue of Equity re Share Stake Scheme
25th Nov 20207:00 amRNSHalf-year Report
22nd Sep 202011:31 amRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Trading Statement and Acquisition Update
3rd Sep 20207:00 amRNSBlock listing Interim Review
1st Sep 20207:00 amRNSReplacement: Final Results
12th Aug 20207:00 amRNSFinal Results
24th Jul 202012:37 pmRNSReplacement: Bond Facility & trading update
15th Jul 202010:45 amRNSBond Facility for up to £50m & trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.